Chimeric Therapeutics Ltd 2022 Sustainability Report
Company: Chimeric Therapeutics Ltd
Sector: Professional & technical services
Country: Australia
Year: 2022
Type: Sustainability Report
Pages: 8
The report presents an initial ESG disclosure against the World Economic Forum's Stakeholder Capitalism Metrics, covering 21 core metrics. It states the company's purpose is to discover, develop and commercialise novel cell therapies with the most curative potential for patients. The report identifies a workforce of nine employees and treats several environmental and workforce metrics as not material or deferred for future reporting.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.